Drugdu.com expert's response:

Pharmaceutical products exported to Japan must obtain certification from Japan's Ministry of Health, Labour and Welfare (MHLW) and meet the following testing and certification requirements:

I. Core Certification Requirements

1. Drug Certification

Basis of Regulations: Primarily based on the Pharmaceutical and Medical Device Act (Pharmaceutical Affairs Law) and the Food Sanitation Act.

Testing Content: Includes ingredient analysis, efficacy evaluation, and safety testing, covering physical and chemical property testing, biological activity testing, and contaminant testing, among others.

Certification Process:

Submit detailed technical documentation and ingredient descriptions of the product.

Provide production process flow and quality control measures.

Submit previous testing reports and certificates of compliance.

Provide relevant clinical trial data (if applicable).

2. Medical Device Certification

PMDA Certification: Medical devices must obtain certification from the Pharmaceuticals and Medical Devices Agency (PMDA), Japan's regulatory body for pharmaceuticals and medical devices, to ensure compliance with Japanese safety, efficacy, and quality standards.

Product Classification: Medical devices are classified into Class I, II, and III based on risk level, with different certification requirements for each class.

Class I: Low-risk products that typically do not require PMDA pre-review but still require product registration and a conformity declaration.

Class II: Medium-risk products that require submission of technical documentation and clinical data for PMDA review.

Class III: High-risk products that require comprehensive clinical validation and detailed technical documentation and must undergo PMDA review and approval.

Certification Process:

Foreign Manufacturer Registration: Conduct formal registration of foreign manufacturers in Japan to ensure that basic company information is on file with Japanese regulatory authorities.

Obtain Importer Qualification: Importers must obtain a "Manufacturing and Sales License for In Vitro Diagnostic Medical Devices" and deploy corresponding professional personnel.

Conduct Manufacturing Industry Registration: For aspects involving the storage and inspection of medical devices, "Manufacturing Industry Registration for In Vitro Diagnostic Medical Devices" is required.

Product Classification and Review: Classify medical devices based on risk level and submit corresponding technical documentation and clinical data (if applicable) for review.

II. Other Related Requirements

Quality Management System: Manufacturers must provide quality management system documentation that complies with ISO 13485 standards, covering aspects such as production processes, quality control, product testing, and supplier management.

Labels and Instructions: Imported pharmaceutical products must have labels and instructions that comply with Japanese requirements, including Japanese-language labels. Labels must include basic product information, usage instructions, safety warnings, etc.

Clinical Trial Data: For high-risk pharmaceutical products (such as Class III medical devices), PMDA typically requires clinical trial data that complies with Good Clinical Practice (GCP) standards to demonstrate product safety and efficacy.

Post-Market Surveillance: Imported pharmaceutical products that have obtained PMDA certification require ongoing surveillance in Japan. Importers and manufacturers must ensure that products comply with Japanese quality management standards and promptly report any adverse events.